Beyond weight loss:
Obesity trial design for real-world patient and payer impact
Obesity drug development is entering a new era.
As obesity therapies reshape the treatment landscape, sponsors face increasing pressure to demonstrate value beyond weight loss alone. Regulators, payers, providers and patients increasingly expect evidence of long-term outcomes, quality of life, adherence and economic impact.
Success in obesity drug development depends on generating evidence that balances scientific rigor with real-world relevance. This requires thoughtful endpoint selection, patient-centric trial strategies and an integrated approach to evidence generation.
Watch our experts explore innovative approaches to designing obesity clinical trials, with practical strategies for creating a stronger evidence package that resonates with regulators, payers and patients alike.
Watch this webinar and learn:
- How obesity trial endpoints are evolving beyond traditional measures of weight reduction
- Strategies for incorporating patient-centric approaches and capturing what matters most to patients
- Considerations for generating payer-relevant evidence earlier in development
- Opportunities to leverage real-world data and patient insights to strengthen development programs
- Best practices for designing studies that demonstrate both clinical and economic value
Design obesity trials that deliver value beyond weight loss: Watch the webinar